Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Loans at 15% just so we can keep pay a scamming CEO

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Dec 22, 2022 2:07pm

134 Views

Post# 35187648

RE:Loans at 15% just so we can keep pay a scamming CEO

that was TBP going to .005 not .05 , Tetra has no new approved products or foreseen revenue in the near future , Reduvo will not save them , it will be sold off so Guy can retain his wage and keep banging test tubes together and making deals on products that will never be .Tetra is broke and dreams cost money.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia